(Q33711382)

28 July 2017

1 reference

title

The biology of Epstein-Barr virus: lessons learned from the virus and the host (English)

1 reference

28 July 2017

0 references

1 reference

Cohen JI

1

1 reference

28 July 2017

1 August 1999

1 reference

Current Opinion in Immunology

28 July 2017

1 reference

28 July 2017

11

1 reference

28 July 2017

4

1 reference

28 July 2017

365-370

1 reference

Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response

28 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980062-4

7 January 2021

Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980062-4

7 January 2021

Large clonal expansions of CD8+ T cells in acute infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980062-4

7 January 2021

A functional link for major TCR expansions in healthy adults caused by persistent Epstein-Barr virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980062-4

7 January 2021

The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980062-4

7 January 2021

Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980062-4

7 January 2021

The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980062-4

7 January 2021

Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980062-4

7 January 2021

Interaction of tumor necrosis factor receptor-associated factor signaling proteins with the latent membrane protein 1 PXQXT motif is essential for induction of epidermal growth factor receptor expression

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980062-4

7 January 2021

Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980062-4

7 January 2021

Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980062-4

7 January 2021

Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980062-4

7 January 2021

Epstein-Barr virus and the immune system. Hide and seek

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980062-4

7 January 2021

Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980062-4

7 January 2021

EBV persistence in memory B cells in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980062-4

7 January 2021

Is EBV persistence in vivo a model for B cell homeostasis?

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980062-4

7 January 2021

Suppression of c-Myc-induced apoptosis by the Epstein-Barr virus gene product BHRF1.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980062-4

7 January 2021

Expression of Epstein-Barr virus latent membrane protein 1 protects Jurkat T cells from apoptosis induced by serum deprivation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980062-4

7 January 2021

Epstein-Barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt's lymphoma cell line Akata.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980062-4

7 January 2021

Epstein-barr virus regulates c-MYC, apoptosis, and tumorigenicity in Burkitt lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980062-4

7 January 2021

Viral interleukin-10 in chronic active Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980062-4

7 January 2021

Retroviral delivery of viral interleukin-10 into myeloid dendritic cells markedly inhibits their allostimulatory activity and promotes the induction of T-cell hyporesponsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980062-4

7 January 2021

The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980062-4

7 January 2021

A minimal glycine-alanine repeat prevents the interaction of ubiquitinated I kappaB alpha with the proteasome: a new mechanism for selective inhibition of proteolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980062-4

7 January 2021

Murine cytotoxic T lymphocytes recognize an epitope in an EBNA-1 fragment, but fail to lyse EBNA-1-expressing mouse cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980062-4

7 January 2021

Human CD8+ T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980062-4

7 January 2021

Evolutionary dynamics of genetic variation in Epstein-Barr virus isolates of diverse geographical origins: evidence for immune pressure-independent genetic drift.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980062-4

7 January 2021

Biology and adoptive cell therapy of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of marrow allografts.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980062-4

7 January 2021

Eradication of latent Epstein-Barr virus by hydroxyurea alters the growth-transformed cell phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2899%2980062-4

7 January 2021

10.1016/S0952-7915(99)80062-4

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10448133